THERAPY OF ADVANCED BLADDER CANCER BY TARGETING HYAL2 WITH ANTIBODY-DRUG CONJUGATE: PRECLINICAL STUDY

被引：0
|
作者：
O'Malley, Padraic
Donelan, William
Hsieh, Meng-Lun
Li, Shiwu
Nguyen, Brianna
Crispen, Paul
Kusmartsev, Sergei
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP65-19
引用
收藏
页码：E1084 / E1084
页数：1
相关论文
共 50 条
  • [41] Lineage plasticity as a determinant of antibody-drug conjugate target expression in urothelial bladder cancer
    Luo, Jiaqian
    Gao, Sizhi P.
    Kuo, Fengshen
    Ozcan, Gamze Gokturk
    Basar, Merve
    Koll, Florestan
    Tallman, Jacob E.
    Alam, Syed M.
    Chu, Carissa E.
    Chen, Ziyu
    Pietzak, Eugene J.
    Iyer, Gopakumar
    Rosenberg, Jonathan E.
    Solit, David B.
    Al-Ahmadie, Hikmat
    CANCER RESEARCH, 2024, 84 (06)
  • [42] An auristatin-based antibody-drug conjugate targeting EphA2 in pancreatic cancer treatment
    Chang, Fu-Ling
    Lee, Cheng-Chung
    Tsai, Keng-Chang
    Lin, Tsai-Yu
    Chiang, Chen-Wei
    Pan, Shiow-Lin
    Lee, Yu-Ching
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 688
  • [43] Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer
    Junttila, Melissa R.
    Mao, Weiguang
    Wang, Xi
    Wang, Bu-Er
    Thinh Pham
    Flygare, John
    Yu, Shang-Fan
    Yee, Sharon
    Goldenberg, David
    Fields, Carter
    Eastham-Anderson, Jeffrey
    Singh, Mallika
    Vij, Rajesh
    Hongo, Jo-Anne
    Firestein, Ron
    Schutten, Melissa
    Flagella, Kelly
    Polakis, Paul
    Polson, Andrew G.
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (314)
  • [44] Developing a novel doppel-targeting antibody-drug conjugate (ADC) for solid cancer
    Lee, Ha Kyeong
    Kim, Byoungmo
    Kweon, Seho
    Choi, Jeong Uk
    Kim, Sang Yoon
    Byun, Youngro
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Development of an antibody-drug conjugate panel targeting high grade serous ovarian cancer
    Fu, Ruisi
    Lou, Hantao
    Wang, Ning
    Yan, Dongnan
    Tresserras-Segura, Clara
    Lu, Haonan
    Aboagye, Eric
    CANCER RESEARCH, 2023, 83 (07)
  • [46] Development and characterization of an epiregulin antibody-drug conjugate for targeting colorectal cancer cell plasticity
    Jacob, Joan
    Liang, Zhengdong
    Carmon, Kendra
    CANCER RESEARCH, 2022, 82 (12)
  • [47] Potential drugs used in the antibody-drug conjugate (ADC) architecture for cancer therapy
    Yaghoubi, Sajad
    Karimi, Mohammad Hossein
    Lotfinia, Majid
    Gharibi, Tohid
    Mahi-Birjand, Motahare
    Kavi, Esmaeil
    Hosseini, Fahimeh
    Sepehr, Koushan Sineh
    Khatami, Mehrdad
    Bagheri, Nader
    Abdollahpour-Alitappeh, Meghdad
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (01) : 31 - 64
  • [48] Folate receptor alpha for cancer therapy: an antibody and antibody-drug conjugate target coming of age
    Liu, Yi
    Chen, Xinyi
    Evan, Theodore
    Esapa, Benjamina
    Chenoweth, Alicia
    Cheung, Anthony
    Karagiannis, Sophia N.
    MABS, 2025, 17 (01)
  • [49] Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancer
    Lei, Huizi
    Ling, Yun
    Yuan, Pei
    Yan, Xieqiao
    Wang, Lin
    Shi, Yanxia
    Yao, Xin
    Luo, Hong
    Shi, Benkang
    Liu, Jiyan
    He, Zhisong
    Yu, Guohua
    Han, Weiqing
    Hu, Changlu
    Chi, Zhihong
    Cui, Chuanliang
    Si, Lu
    Fang, Jianmin
    Guo, Jun
    Sheng, Xinan
    Zhou, Aiping
    Ying, Jianming
    JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (02): : 121 - 128
  • [50] Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple Myeloma
    Springer, Aaron D.
    Wang, Rengang
    Wang, Jiawei
    Du, Qinyi
    Pi, Willie
    Nguyen, Austin Q.
    Li, Xiaoqing
    Khasanov, Alisher
    Zhu, Tong
    Yan, Zheng
    Hong, Yufeng
    Zhou, Heyue
    Zhang, Yanliang
    Kerwin, Lisa
    Li, Lingna
    Ji, Henry
    Zhang, Hong
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (10): : 2660 - 2672
12345